MINORGA

This brand name is authorized in Malta, Poland, Romania

Active ingredients

The drug MINORGA contains one active pharmaceutical ingredient (API):

1 Minoxidil UNII 5965120SH1 - MINOXIDIL

Topical administration of minoxidil stimulates hair growth in men and women with androgenic alopecia. The mechanism of stimulating hair growth from minoxidil is not fully understood, but some actions of minoxidil include increasing hair diameter, stimulating new growth and prolonging the developmental phase, and stimulating hair follicle transition from resting phase (telogen) in the growth phase (regenerative). Read about Minoxidil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MINORGA Cutaneous solution	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D11AX01	Minoxidil	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): MA1106/00201, MA1106/00202
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100325325, 100325331
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64109001, W64109002, W64111001, W64111002